Localisation of PGK1 determines metabolic phenotype to balance metastasis and proliferation in patients with SMAD4-negative pancreatic cancer.
Chen LiangSi ShiYi QinQingcai MengJie HuaQiangshen HuShunrong JiBo ZhangJin XuXian-Jun YuPublished in: Gut (2019)
PGK1 is a decisive oncogene in patients with SMAD4-negative PDAC and can be a target for the development of a therapeutic strategy for SMAD4-negative PDAC.